PMS-ERLOTINIB

Pharmascience Inc🇨🇦 Health Canada

Approval Id: 4e613e417c1c3d35
Drug Approval Canada Name: PMS-ERLOTINIB
Product Name: PMS-ERLOTINIB
Status: Marketed
Status Date: 2016-07-28
Original Market Date: 2016-07-28
Din: 02454386
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 10:00.00
Atc Original: L01EB02 ERLOTINIB
Atc Name: l 01 eb 02
Aig Number: 0151203002
Company Name: Pharmascience Inc
Company Address: 100, 6111 Royalmount Ave, Montreal, Quebec, Canada, H4P 2T4
Company Detail Path: /organization/pharmascience-inc

ERLOTINIB (ERLOTINIB HYDROCHLORIDE)

100 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

4e613e417c1c3d35

Type

Standard